Kiora Pharmaceuticals Statistics
Total Valuation
KPRX has a market cap or net worth of $7.83 million. The enterprise value is -$8.17 million.
| Market Cap | 7.83M |
| Enterprise Value | -8.17M |
Important Dates
The last earnings date was Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KPRX has 6.36 million shares outstanding. The number of shares has increased by 24.68% in one year.
| Current Share Class | 4.42M |
| Shares Outstanding | 6.36M |
| Shares Change (YoY) | +24.68% |
| Shares Change (QoQ) | +1.90% |
| Owned by Insiders (%) | 2.10% |
| Owned by Institutions (%) | 16.25% |
| Float | 3.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.83 |
| Forward PS | n/a |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.91, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.91 |
| Quick Ratio | 7.35 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -445.98 |
Financial Efficiency
Return on equity (ROE) is -67.70% and return on invested capital (ROIC) is -28.98%.
| Return on Equity (ROE) | -67.70% |
| Return on Assets (ROA) | -21.30% |
| Return on Invested Capital (ROIC) | -28.98% |
| Return on Capital Employed (ROCE) | -44.83% |
| Weighted Average Cost of Capital (WACC) | 3.54% |
| Revenue Per Employee | $76,923 |
| Profits Per Employee | -$981,772 |
| Employee Count | 13 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -484,170 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.64% in the last 52 weeks. The beta is -0.14, so KPRX's price volatility has been lower than the market average.
| Beta (5Y) | -0.14 |
| 52-Week Price Change | -46.64% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 2.38 |
| Relative Strength Index (RSI) | 20.85 |
| Average Volume (20 Days) | 68,477 |
Short Selling Information
The latest short interest is 56,588, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 56,588 |
| Short Previous Month | 4,196 |
| Short % of Shares Out | 0.89% |
| Short % of Float | 1.47% |
| Short Ratio (days to cover) | 1.42 |
Income Statement
In the last 12 months, KPRX had revenue of $1.00 million and -$12.76 million in losses. Loss per share was -$2.45.
| Revenue | 1.00M |
| Gross Profit | -2.71M |
| Operating Income | -8.90M |
| Pretax Income | -13.25M |
| Net Income | -12.76M |
| EBITDA | -8.86M |
| EBIT | -8.90M |
| Loss Per Share | -$2.45 |
Balance Sheet
The company has $16.29 million in cash and $286,789 in debt, with a net cash position of $16.00 million or $2.51 per share.
| Cash & Cash Equivalents | 16.29M |
| Total Debt | 286,789 |
| Net Cash | 16.00M |
| Net Cash Per Share | $2.51 |
| Equity (Book Value) | 15.30M |
| Book Value Per Share | 3.46 |
| Working Capital | 17.40M |
Cash Flow
In the last 12 months, operating cash flow was -$7.79 million and capital expenditures -$106,992, giving a free cash flow of -$7.90 million.
| Operating Cash Flow | -7.79M |
| Capital Expenditures | -106,992 |
| Depreciation & Amortization | 43,953 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.90M |
| FCF Per Share | -$1.24 |
Margins
| Gross Margin | -271.42% |
| Operating Margin | -890.17% |
| Pretax Margin | -1,324.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -24.68% |
| Shareholder Yield | -24.68% |
| Earnings Yield | -199.16% |
| FCF Yield | -100.91% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 11, 2024. It was a reverse split with a ratio of 1:9.
| Last Split Date | Jun 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |